These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8673661)

  • 1. Stability of flucytosine in an extemporaneously compounded oral liquid.
    Wintermeyer SM; Nahata MC
    Am J Health Syst Pharm; 1996 Feb; 53(4):407-9. PubMed ID: 8673661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of acetazolamide, allopurinol, azathioprine, clonazepam, and flucytosine in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1996 Aug; 53(16):1944-9. PubMed ID: 8862208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of tacrolimus in an extemporaneously compounded oral liquid.
    Jacobson PA; Johnson CE; West NJ; Foster JA
    Am J Health Syst Pharm; 1997 Jan; 54(2):178-80. PubMed ID: 9117806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of an extemporaneously compounded levothyroxine sodium oral liquid.
    Boulton DW; Fawcett JP; Woods DJ
    Am J Health Syst Pharm; 1996 May; 53(10):1157-61. PubMed ID: 8734676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of itraconazole in an extemporaneously compounded oral liquid.
    Jacobson PA; Johnson CE; Walters JR
    Am J Health Syst Pharm; 1995 Jan; 52(2):189-91. PubMed ID: 12879547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of epinephrine hydrochloride in an extemporaneously compounded topical anesthetic solution of lidocaine, racepinephrine, and tetracaine.
    Larson TA; Uden DL; Schilling CG
    Am J Health Syst Pharm; 1996 Mar; 53(6):659-62. PubMed ID: 8800972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of famotidine in an extemporaneously prepared oral liquid.
    Quercia RA; Jay GT; Fan C; Chow MS
    Am J Hosp Pharm; 1993 Apr; 50(4):691-3. PubMed ID: 8470686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of flecainide acetate in an extemporaneously compounded oral suspension.
    Wiest DB; Garner SS; Pagacz LR; Zeigler V
    Am J Hosp Pharm; 1992 Jun; 49(6):1467-70. PubMed ID: 1529992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of ursodiol 25 mg/mL in an extemporaneously prepared oral liquid.
    Mallett MS; Hagan RL; Peters DA
    Am J Health Syst Pharm; 1997 Jun; 54(12):1401-4. PubMed ID: 9194984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of terbinafine hydrochloride in an extemporaneously prepared oral suspension at 25 and 4 degrees C.
    Abdel-Rahman SM; Nahata MC
    Am J Health Syst Pharm; 1999 Feb; 56(3):243-5. PubMed ID: 10030510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of norfloxacin in an extemporaneously prepared oral liquid.
    Johnson CE; Price J; Hession JM
    Am J Health Syst Pharm; 2001 Apr; 58(7):577-9. PubMed ID: 11296605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of pentoxifylline in an extemporaneously prepared oral suspension.
    Abdel-Rahman S; Nahata MC
    Am J Health Syst Pharm; 1997 Jun; 54(11):1301-3. PubMed ID: 9179352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of ursodiol in an extemporaneously compounded oral liquid.
    Johnson CE; Nesbitt J
    Am J Health Syst Pharm; 1995 Aug; 52(16):1798-1800. PubMed ID: 8528836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of isradipine in an extemporaneously compounded oral liquid.
    MacDonald JL; Johnson CE; Jacobson P
    Am J Hosp Pharm; 1994 Oct; 51(19):2409-11. PubMed ID: 7847406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of extemporaneously compounded temozolomide 10 mg/mL suspensions in Oral Mix SF® in glass and plastic bottles and plastic syringes.
    Lingertat-Walsh K; Weilnau J; Cober MP; Ostrenga A; Poon B; Sales P; Law S; Dupuis LL; Walker SE
    J Oncol Pharm Pract; 2021 Jan; 27(1):78-87. PubMed ID: 32228132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of zonisamide in extemporaneously compounded oral suspensions.
    Abobo CV; Wei B; Liang D
    Am J Health Syst Pharm; 2009 Jun; 66(12):1105-9. PubMed ID: 19498126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of Extemporaneously Compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes.
    Walsh A; Ziegler B; Lingertat-Walsh K; Law S; Walker SE
    Int J Pharm Compd; 2021; 25(2):163-168. PubMed ID: 33798116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term stability of extemporaneously prepared captopril oral liquids in glass bottles.
    Brustugun J; Lao YE; Fagernaes C; Braenden J; Kristensen S
    Am J Health Syst Pharm; 2009 Oct; 66(19):1722-5. PubMed ID: 19767378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of propylthiouracil in extemporaneously prepared oral suspensions at 4 and 25 degrees C.
    Nahata MC; Morosco RS; Trowbridge JM
    Am J Health Syst Pharm; 2000 Jun; 57(12):1141-3. PubMed ID: 10911513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of lamotrigine in two extemporaneously prepared oral suspensions at 4 and 25 degrees C.
    Nahata MC; Morosco RS; Hipple TF
    Am J Health Syst Pharm; 1999 Feb; 56(3):240-2. PubMed ID: 10030509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.